Wiser Pharmaceutical has received a utility patent from the US Patent and Trademark Office. It sold this patent to another pharmaceutical company for $50,000. Under which accounting head did Wiser record the patent in its books of accounts before the sale?
A. expenses
B. income
C. intangible assets
D. tangible assets